What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06853912 - Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Clinical Trial in Seattle, Washington
This study is a phase 2 single-site, double-blind, placebo-controlled, randomized clinical trial with an open-label extension phase to examine the safety of psilocybin (25 mg) combined with psychological support (Psi-PS) for treatment of approximately 40 military veterans and first responders (ages 21-65) with co-occurring alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD). Psychological support i... Source record lists lead sponsor Nathan Brashares Sackett and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06853912
- Last Verified
- 2026-06-12
Location
University of Washington Center for Novel Therapeutics in Addiction Psychiatry, Seattle, Washington
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06853912; status Recruiting; sponsor Nathan Brashares Sackett.
Source: https://clinicaltrials.gov/study/NCT06853912
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.